SCHEMBL144780

SCHEMBL144780

N#Cc1ccc(CNC(=O)ON2CCN(CCC(=O)c3ccc4[nH]c(=O)oc4c3)CC2)cc1

nearest known ligand 0.53

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ENPP2 Q13822 7/20 0.53
GRIN2D O15399 1/20 0.51
GRIN3B O60391 1/20 0.51
GRIN1 Q05586 1/20 0.51
GRIN2A Q12879 1/20 0.51
GRIN2B Q13224 1/20 0.51
GRIN2C Q14957 1/20 0.51
GRIN3A Q8TCU5 1/20 0.51
KCNH2 Q12809 1/20 0.51
KDM4E B2RXH2 1/20 0.40
ALDH1A1 P00352 1/20 0.40
ALPL P05186 1/20 0.38
CREBBP Q92793 1/20 0.38
HTR1A P08908 3/20 0.38
DRD2 P14416 2/20 0.38
HTR7 P34969 1/20 0.37
HTR6 P50406 1/20 0.37
SLC6A2 P23975 1/20 0.37
SLC6A3 Q01959 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL105007 0.89 ENPP2 (0.60) ENPP2GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL3048790 0.88 ENPP2 (0.57) ENPP2GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL105662 0.87 ENPP2 (0.53) ENPP2GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL106235 0.86 ENPP2 (0.67) ENPP2GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL106703 0.86 GRIN2D (0.52) ENPP2GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL104988 0.82 ENPP2 (0.52) ENPP2GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL3061366 0.81 ENPP2 (0.79) ENPP2GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL15135277 0.80 ENPP2 (0.66) ENPP2GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL107319 0.77 GRIN2D (0.61) ENPP2GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL3055653 0.76 ENPP2 (0.65) ENPP2GRIN2DGRIN3BGRIN1GRIN2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2426106-B1 Piperidine and Piperazine derivatives for the treatment of tumours MERCK PATENT GMBH (DE) 2013-07-31 EP claimed
EP-2426106-A1 Piperidine and Piperazine derivatives for the treatment of tumours Merck Patent GmbH (DE) 2012-03-07 EP claimed
EP-2193118-A2 PIPERIDINE AND PIPERAZINE DERIVATIVES FOR TREATING TUMOURS Merck Patent GmbH (DE) 2010-06-09 EP claimed
WO-2009046841-A2 PIPERIDINE AND PIPERAZINE DERIVATIVES FOR TREATING TUMOURS MERCK PATENT GMBH (DE) 2009-04-16 WO claimed
EP-2426106-B1 Piperidine and Piperazine derivatives for the treatment of tumours MERCK PATENT GMBH (DE) 2013-07-31 EP disclosed
EP-2426106-A1 Piperidine and Piperazine derivatives for the treatment of tumours Merck Patent GmbH (DE) 2012-03-07 EP disclosed